Our Mission

Muscle and bone disorders represent a tremendous and further increasing health burden affecting the quality of life of millions of people. The mission of Sirana Pharma is to develop therapies for unmet medical needs in musculoskeletal diseases. To accomplish our mission, we pioneer novel biological approaches and mechanisms to generate innovative first-in-class drugs that improve the integrity and function of diseased skeletal muscle and bone tissues.


Management Team​

Extended Team

Scientific Advisory Board



Announcements of corporate news and company updates.

Sirana Pharma enters into a collaborative research agreement with Pfizer to investigate a novel treatment for a rare bone disease

Sirana Pharma GmbH announces today a collaborative research agreement with Pfizer Inc. to investigate the potential identification and validation of a novel treatment concept for a rare bone disease. The collaboration will utilize Sirana’s proprietary microRNA (miRNA)-targeting approach, which targets substantial regenerative recovery of diseased muscle and bone tissue.


Share this page